Assessment of the implementation of accelerated drug marketing registration procedures for antineoplastic and immunomodulating agents in China: based on 2016–2022 review data

Assessment of the implementation of accelerated drug marketing registration procedures for antineoplastic and immunomodulating agents in China: based on 2016–2022 review data

Objective:Since 2016, China has successively implemented Accelerated Drug Marketing Registration Procedures (ADMRPs) for drugs, including Breakthrough Therapy Drug (BTD), Conditional Approval (CA), and Priority Review and Approval (PRA), which have played an important role in promoting the developme...

Full description

Bibliographic Details
Main Authors: Yipeng Lan, Xiaofeng Lin, Jialin Yu, Li Wang, Lihua Sun, Zhe Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Pharmacology
Subjects:
antineoplastic and immunomodulating agents
accelerated drug marketing registration procedures
drug review and approval
breakthrough therapy drug
conditional approval
priority review and approval
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1345672/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1345672/full

Similar Items